Enasidenib Mesylate and Zinbryta

• Generic Name: enasidenib
• Dosage Forms: n.a.
• Other Brand Names: Idhifa, Idhifa

For the treatment of relapsed or refractory AML with IDH2 mutation (designated an orphan drug by FDA for this use).

FDA-approved diagnostic test (e.g., Abbott RealTime IDH2 assay) required to confirm the presence of IDH2 mutation prior to initiation of therapy.

• Generic Name: daclizumab
• Dosage Forms: injection, solution
• Other Brand Names: Zinbryta, Zenapax

Zinbryta (daclizumab) is a monoclonal antibody that affects the actions of the body's immune system. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage.

Zinbryta is used to treat relapsing forms of multiple sclerosis.

Zinbryta is usually given when other medicines have not been effective.

Zinbryta is available only from a certified pharmacy under a special program. You must be registered in the program and understand the risks and benefits of taking this medicine.